Published in Health and Medicine Week, December 1st, 2003
For the full year, the company reported record revenues of $4.528 billion, a 12% increase over a year ago. At constant foreign exchange rates, revenues increased 5% for the quarter and 8% for the fiscal year. Revenue growth in all segments benefited from favorable foreign currency translation, particularly with respect to the Euro, for the quarter and the year.
Diluted earnings per share and net income for the quarter were 61 cents and $161 million,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.